
Your API's made better! nanoQuick does this by addressing the three primary control points when creating and delivering the API into the body:
BIOAVAILABILITY
When an Active Pharmaceutical Ingredient ("API") is administered intravenously (systemic circulation into the bloodstream), its bioavailability is 100%. However, when oil-soluble API’s are administered via routes other than intravenous, the bioavailability is significantly lower unless the API is part of a formulation designed for the specific points of entry. nanoQuick S, L and H solves this issue by turning these oil-soluble API’s into easily absorbable particles delivering 70%+ (H), 80%+ (L) and 90%+ (S) into the bloodstream.
NANOMETER SIZING
A nanoparticle is a small particle that ranges between 1 to 100 nanometres (“nm”) in size as defined by the stringent European Commission standards. Undetectable by the human eye, nanoparticles can exhibit significantly different physical and chemical properties to their larger material counterparts. nanoQuick creates nanoparticle sizes in the range of < 30 nm. By creating API particle sizes this small absorption is exponentially increased at mouth, throat and stomach locations with effects typically felt in 5 minutes!
Here’s a size of nanoparticles compared to other structures:
Particle Type Diameter Size Range
Nanoparticles: 1 to 100 nm
Coarse particles (dust): 2500 to 10,000 nm
Paper Thickness: 100,000 nm
ABSORPTION PERMEABILITY ENHANCEMENT
nanoQuick incorporates absorption enhancers to improve the absorption of the API. Absorption permeability refers to an agent whose function it is to increase absorption by enhancing membrane permeation. nanoQuick incorporates absorption enhancers to improve the absorption of the API.
